XOMA

XOMA Royalty Corp

Healthcare · Biotechnology

$215.85 sample

+0.17 (+0.08%) 1D

Market cap

$771.4B

Price as of

2026-10-15

Latest filing

8-K · 2026-10-01

Alerts

8

Price$215.85 -2.88% 3M daily closessample

227.67202.22

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 06INSInsider sell: Chief Financial Officer
Oct 01SEC10-Q filed
Sep 23INSInsider buy: 10% owner
Sep 16INSInsider sell: EVP, Operations
Sep 09INSInsider sell: General Counsel
Sep 02INSInsider buy: 10% owner
Aug 27INSInsider buy: EVP, Operations
Aug 24INSInsider sell: 10% owner

Sign up to see the real XOMA record →

Company facts

SEC EDGAR registration

Name: XOMA Royalty Corp
Sector: Healthcare
Industry: Biotechnology
Smart-money score: +32sample, -100 to +100
Reporting currency: USD

Who is positioning in XOMA

sample

Insiders: 23 insider transactions over 90 days, net selling, $428.7M
Congress: 3 members traded over 90 days
Institutions · 13F: 15 funds hold $6.1B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$45.3B +16.8% y/y

Q4 2024Q3 2026

Inventory$27.1B +17.6% y/y

Q4 2024Q3 2026

Accounts receivable$20.2B +14.7% y/y

Q4 2024Q3 2026

Total debt$51.9B +9.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $164.5B +11.4% 3M
Sample peer B: $552.8B -3.6% 3M
Sample peer C: $732.6B -1.0% 3M
Sample peer D: $589.8B +2.0% 3M
Sample peer E: $472.4B -2.0% 3M